Rezolute (RZLT) Depreciation & Amortization (CF) (2017 - 2026)
Rezolute (RZLT) posted Depreciation & Amortization (CF) of $8000.0 for Q1 2026, up 14.29% sequentially from $7000.0 in Q4 2025, and up 14.29% YoY from $7000.0 in Q1 2025.
Powered by 
Analysis
Rezolute (RZLT) Depreciation & Amortization (CF) (2017 - 2026) Analysis & Trends
Rezolute has reported Depreciation & Amortization (CF) for 13 years, with the latest figure at $8000.0 in Q1 2026.
- Quarterly Depreciation & Amortization (CF) rose 14.29% year-over-year to $8000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $31000.0 (up 3.33% YoY) and the FY2025 annual result came in at $31000.0, down 13.89% from the prior year.
- Depreciation & Amortization (CF) grew to $8000.0 in Q1 2026 per RZLT's latest filing, from $7000.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $11000.0 in Q1 2023 and troughed at $3000.0 in Q1 2022.
- A 5-year average of $7411.8 and a median of $8000.0 in 2024 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2022 and 2023: Depreciation & Amortization (CF) slipped 25.0% in 2022, then jumped 266.67% in 2023.
- Over 5 years, Depreciation & Amortization (CF) stood at $7000.0 in 2022, then jumped by 42.86% to $10000.0 in 2023, then slipped by 20.0% to $8000.0 in 2024, then retreated by 12.5% to $7000.0 in 2025, then increased by 14.29% to $8000.0 in 2026.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $8000.0, $7000.0, and $8000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 56.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 123.70 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 40.52 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Rezolute | 477.02 Mn | 477.02 Mn | - | 8,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 8,000.00 |
| Dec 31, 2025 | 7,000.00 |
| Sep 30, 2025 | 8,000.00 |
| Jun 30, 2025 | 8,000.00 |
| Mar 31, 2025 | 7,000.00 |
| Dec 31, 2024 | 8,000.00 |
| Sep 30, 2024 | 8,000.00 |
| Jun 30, 2024 | 7,000.00 |
| Mar 31, 2024 | 9,000.00 |
| Dec 31, 2023 | 10,000.00 |
| Sep 30, 2023 | 10,000.00 |
| Jun 30, 2023 | 9,000.00 |
| Mar 31, 2023 | 11,000.00 |
| Dec 31, 2022 | 7,000.00 |
| Sep 30, 2022 | 3,000.00 |
| Jun 30, 2022 | 3,000.00 |
| Mar 31, 2022 | 3,000.00 |
| Dec 31, 2021 | 3,000.00 |
| Sep 30, 2021 | 4,000.00 |
| Jun 30, 2021 | 3,000.00 |